The University of Chicago Header Logo

Connection

Bulent Aydogan to Myeloablative Agonists

Back to Details
This is a "connection" page, showing publications Bulent Aydogan has written about Myeloablative Agonists.
Bulent Aydogan
Connection Strength
0.256
Myeloablative Agonists
  1. High dose total marrow irradiation (TMI) does not increase long-term toxicity of myeloablative fludarabine/busulfan (FluBu4) conditioning regimen in allogeneic hematopoietic stem cell transplantation (HSCT). Eur J Haematol. 2024 Jul; 113(1):110-116.
    View in: PubMed
    Score: 0.227
  2. Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study. Biol Blood Marrow Transplant. 2014 Dec; 20(12):2034-41.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.